SK29090A3 - £(5-substituted 4-oxo-4h-pyran-2-yl)methyl)chloro-acetates, method of their preparation - Google Patents
£(5-substituted 4-oxo-4h-pyran-2-yl)methyl)chloro-acetates, method of their preparation Download PDFInfo
- Publication number
- SK29090A3 SK29090A3 SK29090A SK29090A SK29090A3 SK 29090 A3 SK29090 A3 SK 29090A3 SK 29090 A SK29090 A SK 29090A SK 29090 A SK29090 A SK 29090A SK 29090 A3 SK29090 A3 SK 29090A3
- Authority
- SK
- Slovakia
- Prior art keywords
- oxo
- preparation
- substituted
- methyl
- pyran
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title claims description 4
- -1 5-substituted 4-oxo-4h-pyran-2-yl Chemical group 0.000 title claims description 3
- 238000000034 method Methods 0.000 title claims description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 5
- 239000008096 xylene Substances 0.000 claims description 5
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 230000004071 biological effect Effects 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 238000009835 boiling Methods 0.000 claims 1
- 238000005660 chlorination reaction Methods 0.000 claims 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical class OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical class OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-M chloroacetate Chemical compound [O-]C(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-M 0.000 description 1
- 229940089960 chloroacetate Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910021424 microcrystalline silicon Inorganic materials 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS90290A CS29090A2 (en) | 1990-01-22 | 1990-01-22 | //5-substituted-4-oxo-4h-pyran-2-yl/methyl-chloroacetates and method of their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK277933B6 SK277933B6 (en) | 1995-08-09 |
| SK29090A3 true SK29090A3 (en) | 1995-08-09 |
Family
ID=5334759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK29090A SK29090A3 (en) | 1990-01-22 | 1990-01-22 | £(5-substituted 4-oxo-4h-pyran-2-yl)methyl)chloro-acetates, method of their preparation |
Country Status (2)
| Country | Link |
|---|---|
| CS (1) | CS29090A2 (cs) |
| SK (1) | SK29090A3 (cs) |
-
1990
- 1990-01-22 SK SK29090A patent/SK29090A3/sk unknown
- 1990-01-22 CS CS90290A patent/CS29090A2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK277933B6 (en) | 1995-08-09 |
| CS29090A2 (en) | 1991-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU705538B2 (en) | N-substituted dioxothiazolidylbenzamide derivatives and the process for preparing the same | |
| JP6249434B1 (ja) | 置換された多環性ピリドン誘導体およびそのプロドラッグを含有する医薬組成物 | |
| CN1832939B (zh) | 用于治疗癌症或病毒病的三杂环化合物、组合物和方法 | |
| CA2986930C (en) | Chemical modulators of signaling pathways and therapeutic use | |
| Doppalapudi et al. | Chemically programmed antibodies: Endothelin receptor targeting CovX-Bodies™ | |
| KR0142189B1 (ko) | 치환된 피리미딘 유도체 | |
| EP0547708B1 (en) | Saccharin derivative proteolytic enzyme inhibitors | |
| HU227830B1 (hu) | 1,2-Difenil-pirrol-származékok, alkalmazásuk és ilyeneket tartalmazó gyógyászati készítmények | |
| Souto et al. | Synthesis and antibacterial activity of conjugates between norfloxacin and analogues of the siderophore vanchrobactin | |
| BRPI0413616A (pt) | 2,4-pirimidinadiaminas úteis no tratamento de doenças neoplásicas, distúrbios inflamatórios e distúrbios do sistema imunológico | |
| ATE396190T1 (de) | Substituierte heteroarylalkansäure und ihre verwendung als inhibitoren der aldose reductase | |
| PT1206484E (pt) | Compostos e composicoes antipicornavirais, suas utilizacoes farmaceuticas e materiais para a sua sintese | |
| Xu et al. | New modification strategy of matrine as Hsp90 inhibitors based on its specific L conformation for cancer treatment | |
| Nikitenko et al. | The discovery of RFI-641 as a potent and selective inhibitor of the respiratory syncytial virus | |
| JP2008509912A (ja) | 医薬品としての複素環化合物 | |
| Brouillette et al. | Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents | |
| Hilgeroth et al. | Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1, 4-dihydropyridines as competitive HIV-1 protease inhibitors | |
| Gediya et al. | Design, synthesis and pharmacological evaluation of novel thiazole derivatives as c-Met kinase inhibitors and anticancer agents | |
| SK29090A3 (en) | £(5-substituted 4-oxo-4h-pyran-2-yl)methyl)chloro-acetates, method of their preparation | |
| Kaye | The Baylis-Hillman entré e to heterocyclic systems-the Rhodes contribution | |
| Khalaf et al. | Unexpected dealkylation during nucleophilic substitution: Synthesis of 2-N, N-dialkylamino benzoxazoles and benzothiazoles | |
| Kumaresan et al. | Synthesis, characterization and anti-inflammatory activity of some novel pyrimidin-2-amines on carrageenan-induced paw edema in balb/c mice | |
| Shcherbakov et al. | Modification of polyfluoro-containing 3-(ethoxycarbonyl) flavones by biogenic amines and amino acids | |
| Maddi et al. | Synthesis and antiinflammatory activity of substituted (2-oxochromen-3-yl) benzamides. | |
| Brown et al. | The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3 (4H)-yl] benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases |